Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03996226 · ClinicalTrials.gov registry record · Phase 1
A Food-Effect Study of E7386 in Healthy Participants
A Phase 1 study of Food Effect in Healthy Participants, sponsored by Eisai.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT03996226: Completed Phase 1 study of Food Effect in Healthy Participants, sponsored by Eisai.
NCT03996226 is a Phase 1 study of Food Effect in Healthy Participants that has completed, run by Eisai. The registered enrollment target is 17 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03996226, a Phase 1 study of Food Effect in Healthy Participants, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to determine the effect of food in healthy participants on the bioavailability of E7386 following single dose administration with and without a meal.
Conditions Studied
Interventions
- DRUG E7386
Study Locations (1)
Texas
- PPD - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-06-07 |
| Est. Completion | 2019-10-29 |
| Phase | Phase 1 |
What the finished NCT03996226 record still lists
NCT03996226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Food Effect in Healthy Participants appearing as the primary indexed condition, and to 1 intervention - of which E7386 is the first listed.
NCT03996226 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03996226 about?
NCT03996226 is a clinical study titled "A Food-Effect Study of E7386 in Healthy Participants". The primary objective of this study is to determine the effect of food in healthy participants on the bioavailability of E7386 following single dose administration with and without a meal.
What is the current status of trial NCT03996226?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2019-06-07. Estimated completion is 2019-10-29.
What conditions does trial NCT03996226 study?
This clinical trial studies the following conditions: Food Effect in Healthy Participants.
What interventions are being tested in trial NCT03996226?
The interventions under investigation include: E7386 (DRUG).
Who is sponsoring clinical trial NCT03996226?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03996226 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03996226's enrollment target sits among peer trials
17 1785th of 2000 higher than 215 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI